Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells

CE Fahey; RJ Milner; K Kow; NJ Bacon; ME Salute

doi:10.1097/CAD.0b013e32836002ba

Back

Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells

Journal article

Peer reviewed

Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells

CE Fahey, RJ Milner, K Kow, NJ Bacon and ME Salute

ANTI-CANCER DRUGS, Vol.24(5), pp.519-526

01/06/2013

DOI: https://doi.org/10.1097/CAD.0b013e32836002ba

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

Pharmacology & Pharmacy

ONCOLOGY

PHARMACOLOGY & PHARMACY

canine osteosarcoma

comparative oncology

masitinib mesylate

tyrosine kinase inhibitor

DOXORUBICIN COMBINATION CHEMOTHERAPY

SIGNAL-TRANSDUCTION INHIBITION

APPENDICULAR OSTEOSARCOMA

GROWTH-FACTOR

IN-VITRO

OSTEO-SARCOMA

NUDE-MICE

DOGS

AMPUTATION

CISPLATIN

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000317392100009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

28 Record Views

14 Times Cited - Web of Science

See more details

Details

Title: Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells
Creators: CE Fahey
RJ Milner
K Kow
NJ Bacon
ME Salute
Publication Details: ANTI-CANCER DRUGS, Vol.24(5), pp.519-526
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Date published: 01/06/2013
Date submitted: 17/05/2017
Identifiers: 99514652502346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells

Abstract

Files and links (1)

Metrics

Details

Usage Policy